Saba, Nabil F.
Blumenschein, George Jr.
Guigay, Joel
Licitra, Lisa
Fayette, Jerome
Harrington, Kevin J.
Kiyota, Naomi
Gillison, Maura L.
Ferris, Robert L.
Jayaprakash, Vijayvel
Li, Li
Brossart, Peter
Funding for this research was provided by:
Bristol-Myers Squibb (P50 CA097190-14)
Royal Marsden/the Institute of Cancer Research (P30 CA047904-28)
National Institute of Health Research Biomedical Research Centre, and Oracle Cancer Trust (R01 CA206517)
The University of Texas MD Anderson Cancer Center
National Institutes of Health (P30 CA016672)
This article is maintained by: Elsevier
Article Title: Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
Journal Title: Oral Oncology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oraloncology.2019.06.017
Content Type: article
Copyright: © 2019 The Authors. Published by Elsevier Ltd.